Optimising Clinical Development in Oncology
|Event Date/Time: Feb 15, 2011||End Date/Time: Feb 16, 2011|
Other challenges include issues such as validating biomarkers, establishing appropriate endpoints (overall outcome that the protocol is designed to evaluate - common endpoints are severe toxicity, disease progression, or death) and data capturing.
The 2nd Annual Optimising Clinical Development in Oncology conference will provide you with a great opportunity to discuss various trial designs, patient recruitment and retention strategies and biomarker validation. Find out how others are tackling the main challenges, through a variety of presentations, workshops and interactive learning opportunities - network with your peers and forge new contacts.